Ex vivo carbon monoxide delivery inhibits intimal hyperplasia in arterialized vein grafts

Cardiovascular Research

Volumn 89, Issue 2, 2011, Pages 457-463

  Nakao, Atsunori ^a   Huang, Chien Sheng ^a,b   Stolz, Donna B ^a   Wang, Yinna ^a   Franks, Jonathan M ^a   Tochigi, Naobumi ^a   Billiar, Timothy R ^a   Toyoda, Yoshiya ^a   Tzeng, Edith ^a   McCurry, Kenneth R ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Carbon monoxide; Hypoxia inducible factor; Intimal hyperplasia; Vascular endothelial growth factor; Vein graft

Indexed keywords

BETA ACTIN; CARBON MONOXIDE; HISTONE H1; HYPOXIA INDUCIBLE FACTOR 1ALPHA; RINGER SOLUTION; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTERY INTIMA PROLIFERATION; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; ELECTRON MICROSCOPY; EX VIVO STUDY; FEASIBILITY STUDY; HUMAN; INTIMA; LEUKOCYTE AGGREGATION; MALE; NONHUMAN; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; RAT; THROMBOCYTE AGGREGATION; VASCULAR ENDOTHELIUM; VEIN GRAFT;

ANIMALS; AORTA, ABDOMINAL; APOPTOSIS; CARBON MONOXIDE; ENDOTHELIAL CELLS; GRAFT OCCLUSION, VASCULAR; HYPERPLASIA; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; INDAZOLES; INTERCELLULAR ADHESION MOLECULE-1; ISOTONIC SOLUTIONS; MALE; RATS; RATS, INBRED LEW; TIME FACTORS; TISSUE AND ORGAN HARVESTING; TISSUE PRESERVATION; TUNICA INTIMA; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR GRAFTING; VENA CAVA, INFERIOR;

EID: 78751517868     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvq298     Document Type: Article

References (38)

1. Nguyen LL, Conte MS, Menard MT, Gravereaux EC, Chew DK, Donaldson MC et al. Infrainguinal vein bypass graft revision: factors affecting long-term outcome. J Vasc Surg 2004;40:916-923.
2. McMillan WD, McCarthy WJ, Bresticker MR, Pearce WH, Schneider JR, Golan JF et al. Mesenteric artery bypass: objective patency determination. J Vasc Surg 1995;21: 729-740.
3. Hayward PA, Hare DL, Gordon I, Buxton BF. Effect of radial artery or saphenous vein conduit for the second graft on 6-year clinical outcome after coronary artery bypass grafting. Results of a randomised trial. Eur J Cardiothorac Surg 2008;34:113-117.
4. Davies MG, Hagen PO. Pathophysiology of vein graft failure: a review. Eur J Vasc Endovasc Surg 1995;9:7-18.
5. Leask RL, Butany J, Johnston KW, Ethier CR, Ojha M. Human saphenous vein coronary artery bypass graft morphology, geometry and hemodynamics. Ann Biomed Eng 2005;33:301-309.
6. Ducasse E, Fleurisse L, Vernier G, Speziale F, Fiorani P, Puppinck P et al. Interposition vein cuff and intimal hyperplasia: an experimental study. Eur J Vasc Endovasc Surg 2004; 27:617-621.
7. Zubilewicz T, Wronski J, Bourriez A, Terlecki P, Guinault AM, Muscatelli-Groux B et al. Injury in vascular surgery-the intimal hyperplastic response. Med Sci Monit 2001;7:316-324.
8. Ramos JR, Berger K, Mansfield PB, Sauvage LR. Histologic fate and endothelial changes of distended and nondistended vein grafts. Ann Surg 1976;183:205-228.
9. Kohler TR, Kirkman TR, Clowes AW. The effect of rigid external support on vein graft adaptation to the arterial circulation. J Vasc Surg 1989;9:277-285.
10. Otterbein LE. Carbon monoxide: innovative anti-inflammatory properties of an age-old gas molecule. Antioxid Redox Signal 2002;4:309-319.
11. Nakao A, Choi AM, Murase N. Protective effect of carbon monoxide in transplantation. J Cell Mol Med 2006;10:650-671.
12. Otterbein LE, Zuckerbraun BS, Haga M, Liu F, Song R, Usheva A et al. Carbon monoxide suppresses arteriosclerotic lesions associated with chronic graft rejection and with balloon injury. Nat Med 2003;9:183-190.
13. Ramlawi B, Scott JR, Feng J, Mieno S, Raman KG, Gallo D et al. Inhaled carbon monoxide prevents graft-induced intimal hyperplasia in swine. J Surg Res 2007;138: 121-127.
14. Raman KG, Barbato JE, Ifedigbo E, Ozanich BA, Zenati MS, Otterbein LE et al. Inhaled carbon monoxide inhibits intimal hyperplasia and provides added benefit with nitric oxide. J Vasc Surg 2006;44:151-158.
15. Morisaki H, Katayama T, Kotake Y, Ito M, Tamatani T, Sakamoto S et al. Roles of carbon monoxide in leukocyte and platelet dynamics in rat mesenteric during sevo- flurane anesthesia. Anesthesiology 2001;95:192-199.
16. Morisaki H, Katayama T, Kotake Y, Ito M, Handa M, Ikeda Y et al. Carbon monoxide modulates endotoxin-induced microvascular leukocyte adhesion through plateletdependent mechanisms. Anesthesiology 2002;97:701-709.
17. Brouard S, Otterbein LE, Anrather J, Tobiasch E, Bach FH, Choi AM et al. Carbon monoxide generated by heme oxygenase 1 suppresses endothelial cell apoptosis. J Exp Med 2000;192:1015-1026.
18. Zhang X, Shan P, Alam J, Fu XY, Lee PJ. Carbon monoxide differentially modulates STAT1 and STAT3 and inhibits apoptosis via a phosphatidylinositol 3-kinase/Akt and p38 kinase-dependent STAT3 pathway during anoxia-reoxygenation injury. J Biol Chem 2005;280:8714-8721.
19. Faleo G, Neto JS, Kohmoto J, Tomiyama K, Shimizu H, Takahashi T et al. Carbon monoxide ameliorates renal cold ischemia-reperfusion injury with an upregulation of vascular endothelial growth factor by activation of hypoxia-inducible factor. Transplantation 2008;85:1833-1840.
20. Nakao A, Toyokawa H, Tsung A, Nalesnik MA, Stolz DB, Kohmoto J et al. Ex vivo application of carbon monoxide in University of Wisconsin solution to prevent intestinal cold ischemia/reperfusion injury. Am J Transplant 2006;6:2243-2255.
21. Nakao A, Schmidt J, Harada T, Tsung A, Stoffels B, Cruz RJ Jr et al. A single intraperitoneal dose of carbon monoxide-saturated ringer's lactate solution ameliorates postoperative ileus in mice. J Pharmacol Exp Ther 2006;319:1265-1275.
22. Sun H, Valdivia LA, Subbotin V, Aitouche A, Fung JJ, Starzl TE et al. Improved surgical technique for the establishment of a murine model of aortic transplantation. Microsurgery 1998;18:368-371.
23. Hoch JR, Stark VK, Hullett DA, Turnipseed WD. Vein graft intimal hyperplasia: leukocytes and cytokine gene expression. Surgery 1994;116:463-470.
24. Nakao A, Neto JS, Kanno S, Stolz DB, Kimizuka K, Liu F et al. Protection against ischemia/ reperfusion injury in cardiac and renal transplantation with carbon monoxide, biliverdin and both. Am J Transplant 2005;5:282-291.
25. Nakao A, Kimizuka K, Stolz DB, Neto JS, Kaizu T, Choi AM et al. Carbon monoxide inhalation protects rat intestinal grafts from ischemia/reperfusion injury. Am J Pathol 2003;163:1587-1598. (Pubitemid 37175105)
26. Westerband A, Crouse D, Richter LC, Aguirre ML, Wixon CC, James DC et al. Vein adaptation to arterialization in an experimental model. J Vasc Surg 2001;33:561-569.
27. Springer TA. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 1994;76:301-314.
28. Ip JH, Fuster V, Badimon L, Badimon J, Taubman MB, Chesebro JH. Syndromes of accelerated atherosclerosis: role of vascular injury and smooth muscle cell proliferation. J Am Coll Cardiol 1990;15:1667-1687.
29. Nakao A, Murase N, Ho C, Toyokawa H, Billiar TR, Kanno S. Biliverdin administration prevents the formation of intimal hyperplasia induced by vascular injury. Circulation 2005;112:587-591.
30. Dobrin PB. Mechanical factors associated with the development of intimal and medial thickening in vein grafts subjected to arterial pressure. A model of arteries exposed to hypertension. Hypertension 1995;26:38-43.
31. Crowe DM, Hurley JV, Mitchell GM, Niazi Z, Morrison WA. Long-term studies of cold-stored rabbit femoral artery and vein autografts. Br J Plast Surg 1998;51:291-299.
32. Chin BY, Jiang G, Wegiel B, Wang HJ, Macdonald T, Zhang XC et al. Hypoxia-inducible factor 1alpha stabilization by carbon monoxide results in cytoprotective preconditioning. Proc Natl Acad Sci USA 2007;104:5109-5114.
33. Forsythe JA, Jiang BH, Iyer NV, Agani F, Leung SW, Koos RD et al. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol Cell Biol 1996;16:4604-4613.
34. Semenza GL. Targeting HIF-1 for cancer therapy. Nat Rev Cancer 2003;3:721-732.
35. Luo Z, Asahara T, Tsurumi Y, Isner JM, Symes JF. Reduction of vein graft intimal hyperplasia and preservation of endothelium-dependent relaxation by topical vascular endothelial growth factor. J Vasc Surg 1998;27:167-173.
36. Asahara T, Bauters C, Pastore C, Kearney M, Rossow S, Bunting S et al. Local delivery of vascular endothelial growth factor accelerates reendothelialization and attenuates intimal hyperplasia in balloon-injured rat carotid artery. Circulation 1995;91: 2793-2801.
37. Reinders ME, Sho M, Izawa A, Wang P, Mukhopadhyay D, Koss KE et al. Proinflammatory functions of vascular endothelial growth factor in alloimmunity. J Clin Invest 2003; 112:1655-1665.
38. Tsuchihashi S, Ke B, Kaldas F, Flynn E, Busuttil RW, Briscoe DM et al. Vascular endothelial growth factor antagonist modulates leukocyte trafficking and protects mouse livers against ischemia/reperfusion injury. Am J Pathol 2006;168: 695-705.